The rapid clinical validation of mRNA technology during the COVID‑19 pandemic has powerfully accelerated its application in ...

N6-methyladenosine (m6A), the most abundant internal modification in eukaryotic mRNA, serves as a pivotal epitranscriptomic ...

Researchers, materials scientists, and engineers have eight days to help shape what could become the U.S. military’s next ...

Secretary of Defense Pete Hegseth took issue with the AI company's refusal to remove two narrow contractual restrictions on ...

RGX-202 met the main goal of a Phase 3 DMD trial, and Regenxbio plans to seek accelerated approval for the gene therapy.

Cisco (NASDAQ: CSCO) today announced the Cisco Universal Quantum Switch, a critical milestone in quantum networking that ...

Research Describes the Potential of JCR’s Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR ...

Georgetown Lombardi researchers have identified RAGE, an inflammatory receptor, as a key mediator of age-related breast ...

A new AI-driven architecture is dividing the SaaS landscape into two camps. The vendors who built moats around beautiful ...

Confluent Intelligence and Confluent Cloud streamline how real-time, artificial intelligence (AI) applications are built and ...

The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, ...